Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)
Clinical trial NCT04146896 · COMPLETED
Trial details
- NCT number
- NCT04146896
- Sponsor
- Aptinyx
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-12
- Primary completion
- 2022-02-23
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.